Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C
Braz. j. infect. dis
; 14(2): 193-196, Mar.-Apr. 2010. ilus, tab
Article
in English
| LILACS
| ID: lil-548473
Responsible library:
BR1.1
ABSTRACT
Hemodialysis patient with chronic HCV infection,who was started on monotherapy with interferon.Qualitative HCV RNA remained positive at 12 weeks of treatment; ribavirin was associated. HCV RNA was negative at week 24 and treatment was extended to 72 weeks. HCV RNA negative six months after treatment.
Full text:
Available
Collection:
International databases
Health context:
SDG3 - Health and Well-Being
Health problem:
Target 3.3: End transmission of communicable diseases
Database:
LILACS
Main subject:
Antiviral Agents
/
Ribavirin
/
Renal Dialysis
/
Interferons
/
Hepatitis C, Chronic
Type of study:
Qualitative research
Limits:
Adult
/
Humans
/
Male
Language:
English
Journal:
Braz. j. infect. dis
Journal subject:
Communicable Diseases
Year:
2010
Document type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Universidade Estadual de Campinas/BR
